Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could ...

Cas9, the University of Bayreuth’s Biomaterials research group was able to bioengineer a common house spider to produce glowing red silk. Professor Thomas Scheibel and doctoral student Edgardo ...

Beginning a chain of events that will presumably lead to the origin of our universe's Spider-Man, researchers in Germany have ...

On May 12, 2025, the U.S. Court of Appeals for the Federal Circuit issued a long-awaited decision in Regents of the University of California v.

Max Lian gets you up to date with some of the latest scientific news, including gene editing and electricity-storing cement ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Medable has launched a digital-first long-term follow-up (LTFU) model intended for cell and gene therapy (CGT) trials, aiming ...

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...

Medable Inc., a leading technology platform provider for decentralized clinical trials, today unveiled its digital-first Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials.

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...